North America Balloon Catheters Market Report and Forecast 2024-2032

The North America balloon catheters market size was valued at USD 1.3 billion in 2023. It is expected to grow at a CAGR of 10.59% during the forecast period of 2024-2032, driven by the rising prevalence of cardiovascular diseases in the region. The market is estimated to reach a value of USD 3.3 billion by 2032.

Key Takeaways

• In December 2023, the United States Food and Drug Administration (FDA) approved Summa Therapeutics’ Finesse Injectable angioplasty balloon catheters for the treatment of peripheral artery disease.
• In December 2023, an Exclusive Commercial Agreement was signed between HR Pharmaceuticals, Inc. (HRP) and Poiesis Medical LLC, which granted HRP the rights to commercialize Poiesis's Dual Balloon Catheter (Duette™) in North America.
• In the United States, heart disease is the leading cause of mortality, with Centers for Disease Control and Prevention data reporting that one individual dies every 33 seconds from cardiovascular disease.

Balloon catheters have an inflatable balloon at the tip, which can enlarge a narrow opening in a catheterization procedure. The minimally invasive nature of the device is attracting high demand in the market for various medical interventions such as angioplasty and stenting. With a rising patient inclination towards minimally invasive procedures due to certain benefits including reduced surgical trauma and shortened recovery time, North America balloon catheters market demand is expected to witness a surge in the forecast period.

The market is experiencing improvement in the regulatory landscape which boosts the growth. Faster regulatory approvals not only enhance access to novel balloon catheter products but also increase their adoption rates in the healthcare sector. In December 2023, the United States Food and Drug Administration (FDA) approved the Finesse Injectable angioplasty balloon catheters developed by Summa Therapeutics, LLC (a United States-based medical devices company), for the percutaneous transluminal angioplasty (PTA) treatment of peripheral artery disease. The Finesse product line includes a port for injecting radiopaque contrast material coupled with its performance of balloon angioplasty, making it an advanced toolset for angioplasty procedures. The availability of such innovative products in healthcare settings is anticipated to propel North America balloon catheters market share in the forecast period.

In December 2023, an Exclusive Commercial Agreement was signed between a medical equipment manufacturer in the United States, HR Pharmaceuticals, Inc. (HRP), and Poiesis Medical LLC (a medical device company in Florida). As per the terms of collaboration, HRP received the rights to commercialize Poiesis's Dual Balloon Catheter (Duette™) in North America. This Dual Balloon Catheter technology is designed for patients enduring prolonged catheterization and exhibits better results as compared to traditional Foley Catheters. The increased access to such innovative balloon catheter products to the rising patient population in the region is likely to fuel market growth. The rise in strategic partnerships among the key market players which support the market expansion of balloon catheter devices marks as one of the most significant North America balloon catheters market trends.

Other factors that drive the market value include the presence of advanced infrastructure. The growing elderly population more prone to cardiovascular diseases is also poised to directly affect the market demand. Further, the existence of several leading market players and premium research institutions positively impacts the market landscape.

North America Balloon Catheters Market Segmentation

“North America Balloon Catheters Market Report and Forecast 2024-2032” offers a detailed analysis of the market based on the following segments:

Market Breakup by Product Type

• PTA Balloon Catheters
• PTCA Balloon Catheters
• Occlusion Balloon Catheters
• Foley Catheters
• Nephrostomy Balloon Catheters
• Drug -Eluting Catheters
• Normal Balloon Catheter
• Cutting Balloon Catheter
• Scoring Balloon Catheter
• Drug Eluting Balloon Catheter
• Stent Graft Balloon Catheter
• Others

Market Breakup by Catheter Type

• Fixed Wire
• Over -The -Wire
• Rapid Exchange

Market Breakup by Balloon Type

• Non-Compliant
• Semi-Compliant
• Compliant

Market Breakup by Material

• Polyurethane
• Nylon
• Others

Market Breakup by Indication

• Coronary Artery Disease
• Peripheral Vascular Disease

Market Breakup by End User

• Hospitals
• Specialty Clinics
• Others

Market Breakup by Countries

• United States of America
• Canada

North America Balloon Catheters Market: Competitor Landscape

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Abbott Laboratories
• Becton Dickinson and Company
• Boston Scientific Corporation
• Bard Medical Division
• B.Braun Melsungen AG
• Johnson & Johnson
• Teleflex Incorporated
• Medtronic, Plc.
• Edwards Lifesciences Corporation
• Vascular Solutions, Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

FAQs

What was the North America balloon catheters market value in 2023?
The market attained a value of D 1.3 billion in 2023 driven by driven by the rising prevalence of cardiovascular diseases in the region.

What is the North America balloon catheters market forecast outlook for 2024-2032?
The market is anticipated to grow at a CAGR of 10.59% during the forecast period of 2024-2032, likely to reach a market value of USD 3.3 billion by 2032.

What are the major factors aiding the North America balloon catheters market demand?
Advancements in balloon catheter technology and rising healthcare expenditure are fuelling the demand for the regional market.

What are the major North America balloon catheters market trends?
One of the significant trends in the market is the rise in strategic partnerships among the key market players. In December 2023, HR Pharmaceuticals, Inc. (HRP) and Poiesis Medical LLC, signed an exclusive commercial agreement which granted HRP the rights to commercialize Poiesis's Dual Balloon Catheter (Duette™) in North America.

What is the market segmentation based on the product type?
Based on the product type, the market is segmented into PTA balloon catheters, PTCA balloon catheters, occlusion balloon catheters, foley catheters, nephrostomy balloon catheters, drug-eluting catheters, normal balloon catheter, cutting balloon catheter, scoring balloon catheter, drug eluting balloon catheter, and stent graft balloon catheter, among others.

What is the market segmentation based on the catheter type?
Based on the product type, the market is segmented into fixed wire, over-the-wire, and rapid exchange catheter.

What are the major end users of balloon catheters in the market?
Major end users include hospitals and specialty clinics, among others.

What is the market breakup by material?
Based on the material, the market includes polyurethane, and nylon, among others.

What is the market breakup by balloon type?
Based on the balloon type, the market includes non-compliant, semi-compliant, and compliant catheters.

What is the market breakup by indication?
Based on indication, the market includes coronary artery disease and peripheral vascular disease.

What is the market segmentation by countries?
The market segmentation by countries includes the United States of America and Canada.

Who are the key players involved in the North America balloon catheters market?
The key market players are Abbott Laboratories, Becton Dickinson and Company, Boston Scientific Corporation, Bard Medical Division, B.Braun Melsungen AG, Johnson & Johnson, Teleflex Incorporated, Medtronic PLC, Edwards Lifesciences Corporation, and Vascular Solutions, Inc.


This product will be delivered within 5-7 business days.